Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
Medications should not be disposed of through drains or trash. Dispose of the packaging and unused medications at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Etoricoxib pensa
Nucleus of the tablet: microcrystalline cellulose (E460), calcium hydrogen phosphate, croscarmellose sodium, and magnesium stearate (E470b).
Coating of the tablet:
Appearance of the product and contents of the package:
Film-coated tablet.
Etoricoxib pensa 30 mg film-coated tablets EFG:
Blue-green film-coated tablets, apple-shaped, biconvex, engraved with "30" on one side and smooth on the other, with dimensions of 5.8 x 5.9 mm ± 7.5%.
Etoricoxib pensa 60 mg film-coated tablets EFG:
Dark green film-coated tablets, apple-shaped, biconvex, engraved with "60" on one side and smooth on the other, with dimensions of 7.1 x 7.3 mm ± 7.5%.
Etoricoxib pensa 90 mg film-coated tablets EFG:
White film-coated tablets, apple-shaped, biconvex, engraved with "90" on one side and smooth on the other, with dimensions of 8.1 x 8.3 mm ± 7.5%.
Etoricoxib pensa 120 mg film-coated tablets EFG:
Light green film-coated tablets, apple-shaped, biconvex, engraved with "120" on one side and smooth on the other, with dimensions of 8.9 x 9.2 mm ± 7.5%.
Etoricoxib pensa is presented in perforated unit-dose blisters.
Package sizes:
30 mg:
7, 20, and 28 film-coated tablets.
60 mg:
7, 20, and 28 film-coated tablets.
90 mg:
7, 20, and 28 film-coated tablets.
120 mg:
5, 7, and 28 film-coated tablets.
Only some package sizes may be marketed.
Marketing authorization holder:
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Responsible for manufacturing:
Rontis Hellas Medical and Pharmaceutical Products S.A.
P.O. Box 3012 Larisa Industrial Area, Larisa 41004 Greece
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Portugal: Etoricoxib toLife 30mg, 60mg, 90mg, 120mg film-coated tablets
Italy: Etoricoxib Pensa 30mg, 60mg, 90mg, 120mg film-coated tablets
Spain: Etoricoxib pensa 30mg, 60mg, 90mg, and 120mg film-coated tablets EFG
Last review date of this prospectus: December 2016
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.